Skip to main content

Cardio-Oncology

Ausgabe 1/2024

Inhalt (33 Artikel)

Open Access Research

Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: a retrospective cohort analysis

Sinal Patel, Francisco X. Franco, Malcolm McDonald, Carlos Rivera, Bernardo Perez-Villa, Patrick Collier, Rohit Moudgil, Neha Gupta, Diego B. Sadler

Open Access Research

Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors

Moran Gvili Perelman, Rafael Y. Brzezinski, Barliz Waissengrin, Yasmin Leshem, Or Bainhoren, Tammi Arbel Rubinstein, Maxim Perelman, Zach Rozenbaum, Ofer Havakuk, Yan Topilsky, Shmuel Banai, Ido Wolf, Michal Laufer-Perl

Open Access Research

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa

Open Access Correction

Correction: The toxic tango: TKI and ICI cardiotoxicities

Juan Del Cid Fratti, Vijayasree Paleru, Madhuri Bajaj, Chetan Bhardwaj

Open Access Correction

Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study

Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa

Open Access Correspondence

How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized?

Arsalan Hamid, Gregg C. Fonarow, Javed Butler, Michael E. Hall

Open Access Research

Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost

Yvonne Koop, Femke Atsma, Marilot C.T. Batenburg, Hanneke Meijer, Femke van der Leij, Roxanne Gal, Sanne G.M. van Velzen, Ivana Išgum, Hester Vermeulen, Angela H.E.M. Maas, Saloua El Messaoudi, Helena M. Verkooijen

Open Access Review

Pericardial effusion in oncological patients: current knowledge and principles of management

S. Mori, M. Bertamino, L. Guerisoli, S. Stratoti, C. Canale, P Spallarossa, I. Porto, P. Ameri

Open Access Review

The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials

Ahmed Mazen Amin, Yehya Khlidj, Mohamed Abuelazm, Ahmed A. Ibrahim, Mohammad Tanashat, Muhammad Imran, Abubakar Nazir, Hosam Shaikhkhalil, Basel Abdelazeem

Open Access Case Report

Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest

Maciej Kabat, Roma Padalkar, Sara Hazaveh, Vladimir Joseph, David Feigenblum, Sean Sadikot

Open Access Research

Home-based self-management multimodal cancer interventions & cardiotoxicity: a scoping review

Anna Talty, Roseanne Morris, Carolyn Deighan

Open Access Research

Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer

Ahmed A. Fawzy, Khaled A. El-Menyawi, Walid M. Sallam, Mohamed E. Zahran

Open Access Correspondence

Late cardiotoxicity related to HER2-targeted cancer therapy

Isabelle Senechal, Maria Sol Andres, Jieli Tong, Ylenia Perone, Sivatharshini Ramalingam, Muhummad Sohaib Nazir, Stuart D Rosen, Nicholas Turner, Alistair Ring, Alexander R Lyon

Open Access Research

Early reduction in cardiorespiratory fitness and diastolic reserve following radiation therapy for lung cancer

Georgia Thomas, Elisabeth Weiss, Marco Giuseppe Del Buono, Francesco Moroni, Josh West, Rachel Myers, Emily Kontos, Michele Golino, Antonio Abbate, Justin M. Canada

Open Access Research

Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction

Azin Alizadehasl, Mina Mohseni, Kamran Roudini, Parisa Firoozbakhsh

Open Access Research

Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients

Mantasha Tabassum, Soumya G. Chikermane, Camille Johnson, Noor M. Abdulkareem, Elisabeth M. Wang, Michael L. Johnson, Meghana V. Trivedi

Open Access Research

Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study

Massimiliano Camilli, Marcello Viscovo, Tamara Felici, Luca Maggio, Federico Ballacci, Giacomo Carella, Alice Bonanni, Priscilla Lamendola, Lorenzo Tinti, Antonio Di Renzo, Giulia Coarelli, Eugenio Galli, Giovanna Liuzzo, Francesco Burzotta, Rocco Antonio Montone, Federica Sorà, Simona Sica, Stefan Hohaus, Gaetano Antonio Lanza, Filippo Crea, Antonella Lombardo, Giorgio Minotti

Open Access Research

Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma

Anders W Bjerring, Knut HB Smeland, Thomas Stokke, Kristina H Haugaa, Espen Holte, Assami Rösner, Cecilie E Kiserud, Thor Edvardsen, Sebastian Imre Sarvari

Open Access Review

A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors

Nathanya Baez Hernandez, Ksenya Shliakhtsitsava, Drishti Tolani, Cindy Cochran, Ryan Butts, Judith Bonifacio, Elizabeth Journey, Jenna N. Oppenheim, Sarah G. Pennant, Kimberly Arnold, Terri McCaskill, Daniel C. Bowers

Open Access Research

Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study

Kundan Chufal, Irfan Ahmad, Anuj Prakash, Alexis Miller, Preetha Umesh, Varsha Koul, Ram Bajpai, Bharat Dua, Priya Gupta, Munish Gairola

Open Access Research

Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics

Karen Abboud, Godsfavour Umoru, Barry Trachtenberg, Veronica Ajewole

Open Access Case Report

Cancer therapy related cardiac dysfunction as a result of Panitumumab

Isabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, Jieli Tong, Sivatharshini Ramalingam, Stuart D Rosen, Alexander R Lyon, Muhummad Sohaib Nazir

Open Access Research

Right ventricle involvement in patients with breast cancer treated with chemotherapy

Ludovico Rossetto, Daniela Di Lisi, Cristina Madaudo, Francesco Paolo Sinagra, Antonio Di Palermo, Oreste Fabio Triolo, Grazia Gambino, Antonella Ortello, Alfredo Ruggero Galassi, Giuseppina Novo

Open Access Case Report

Nonbacterial thrombotic endocarditis of mitral valve associated with a lymphoproliferative malignancy: case report and literature review

Fabiana Duarte, Maria Inês Barradas, Ana Raquel Dias, Carlos Faria, Carina Machado, Carolina Pavão

Open Access Research

Variants in structural cardiac genes in patients with cancer therapy-related cardiac dysfunction after anthracycline chemotherapy: a case control study

Hanne M. Boen, Maaike Alaerts, Inge Goovaerts, Johan B. Saenen, Constantijn Franssen, Anne Vorlat, Tom Vermeulen, Hein Heidbuchel, Lut Van Laer, Bart Loeys, Emeline M. Van Craenenbroeck

Open Access Research

Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time

Adnan Shaaban, Ashley Petersen, Heather Beckwith, Natalia Florea, David A. Potter, Douglas Yee, Rachel I. Vogel, Daniel Duprez, Anne H. Blaes

Open Access Research

Formative research to adapt a cardiac rehabilitation program to breast cancer survivors: the heart health after cancer treatment (HEART-ACT) study

Alison Chang, Alisa Boyd, Ivan Leung, Evelin Trejo, Niharika Dixit, Jaya Mallidi, Sithu Win, Alexis L. Beatty

Open Access Research

Immune checkpoint inhibitors and pericardial disease: a systematic review

Sarah E. Mudra, Danny L. Rayes, Ankit Agrawal, Ashwin K. Kumar, Jason Z. Li, Meredith Njus, Kevin McGowan, Kazi A. Kalam, Charalompos Charalampous, Mary Schleicher, Muhammad Majid, Alvena Syed, Abdullah Yesilyaprak, Allan L. Klein

Open Access Case Report

Complex decision making in a patient with lung cancer with incidentally found fast-growing atrial mass

Prince Otchere, Stella Pak, Juan Ulloa-Rodriguez, Maria Fierro, Aditi Sharma, Tevonne Poku, Brandon Kofi-Obeng, Eric Yang, Keerthi Thallapureddy

Open Access Case Report

Secondary cardiac lymphoma presenting with cardiac tamponade and cardiac mass: a case report

Wei Juan Lim, Neerusha Kaisbain, Rafidah Abu Bakar, Hafidz Abd Hadi, Ahmad Khairuddin Mohamed Yusof

Open Access Research

Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab

Santiago Luna-Alcala, Adrián Espejel-Guzmán, Claudia Lerma, Paula Leon, Enrique C. Guerra, Jose Rodrigo Espinosa Fernández, Pavel Martinez-Dominguez, Javier Serrano-Roman, Aldo Cabello-Ganem, Alexis D. Aparicio-Ortiz, Candace Keirns, Abel Lerma, Maria Jose Santa Ana-Bayona, Nilda Espinola-Zavaleta

Open Access Research

Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)—an analysis of an administrative health claims database

Srilakshmi Vallabhaneni, Srinath Adusumalli, Jingyi Wu, Peter W. Groeneveld, James Gerson, Rupal P. O’Quinn

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.